Literature DB >> 19652089

Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.

Daniel J Rader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19652089      PMCID： PMC3315106          DOI： 10.1161/CIRCULATIONAHA.109.881979

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  39 in total

1.  Illuminating HDL--is it still a viable therapeutic target?

Authors:  Daniel J Rader
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

2.  Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Authors:  Ruth Frikke-Schmidt; Børge G Nordestgaard; Maria C A Stene; Amar A Sethi; Alan T Remaley; Peter Schnohr; Peer Grande; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

3.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

4.  Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.

Authors:  Laurent Yvan-Charvet; Fumihiko Matsuura; Nan Wang; Mark J Bamberger; Tu Nguyen; Franz Rinninger; Xian-Cheng Jiang; Charles L Shear; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-22       Impact factor: 8.311

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 6.  HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

Authors:  Alan R Tall; Laurent Yvan-Charvet; Naoki Terasaka; Tamara Pagler; Nan Wang
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

7.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.

Authors:  Daniel J Rader; Eric T Alexander; Ginny L Weibel; Jeffrey Billheimer; George H Rothblat
Journal:  J Lipid Res       Date:  2008-12-08       Impact factor: 5.922

8.  Functional LCAT is not required for macrophage cholesterol efflux to human serum.

Authors:  Laura Calabresi; Elda Favari; Elsa Moleri; Maria Pia Adorni; Matteo Pedrelli; Sara Costa; Wendy Jessup; Ingrid C Gelissen; Petri T Kovanen; Franco Bernini; Guido Franceschini
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

9.  Role of LCAT in HDL remodeling: investigation of LCAT deficiency states.

Authors:  Bela F Asztalos; Ernst J Schaefer; Katalin V Horvath; Shizuya Yamashita; Michael Miller; Guido Franceschini; Laura Calabresi
Journal:  J Lipid Res       Date:  2006-12-20       Impact factor: 5.922

10.  Common variants at 30 loci contribute to polygenic dyslipidemia.

Authors:  Sekar Kathiresan; Cristen J Willer; Gina M Peloso; Serkalem Demissie; Kiran Musunuru; Eric E Schadt; Lee Kaplan; Derrick Bennett; Yun Li; Toshiko Tanaka; Benjamin F Voight; Lori L Bonnycastle; Anne U Jackson; Gabriel Crawford; Aarti Surti; Candace Guiducci; Noel P Burtt; Sarah Parish; Robert Clarke; Diana Zelenika; Kari A Kubalanza; Mario A Morken; Laura J Scott; Heather M Stringham; Pilar Galan; Amy J Swift; Johanna Kuusisto; Richard N Bergman; Jouko Sundvall; Markku Laakso; Luigi Ferrucci; Paul Scheet; Serena Sanna; Manuela Uda; Qiong Yang; Kathryn L Lunetta; Josée Dupuis; Paul I W de Bakker; Christopher J O'Donnell; John C Chambers; Jaspal S Kooner; Serge Hercberg; Pierre Meneton; Edward G Lakatta; Angelo Scuteri; David Schlessinger; Jaakko Tuomilehto; Francis S Collins; Leif Groop; David Altshuler; Rory Collins; G Mark Lathrop; Olle Melander; Veikko Salomaa; Leena Peltonen; Marju Orho-Melander; Jose M Ordovas; Michael Boehnke; Gonçalo R Abecasis; Karen L Mohlke; L Adrienne Cupples
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330
View more
  10 in total

Review 1.  Novel HDL-directed pharmacotherapeutic strategies.

Authors:  Emil M Degoma; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2011-01-18       Impact factor: 32.419

2.  Traversing the valley of death: a guide to assessing prospects for translational success.

Authors:  Barry S Coller; Robert M Califf
Journal:  Sci Transl Med       Date:  2009-12-09       Impact factor: 17.956

3.  Clinical Implications of Lipid Genetics for Cardiovascular Disease.

Authors:  Alanna Strong; Daniel J Rader
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-10

Review 4.  Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?

Authors:  Xavier Rousset; Robert Shamburek; Boris Vaisman; Marcelo Amar; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 5.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

Review 6.  Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors:  Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

Review 7.  High-density lipoproteins, reverse cholesterol transport and atherogenesis.

Authors:  Henry J Pownall; Corina Rosales; Baiba K Gillard; Antonio M Gotto
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

Review 8.  Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.

Authors:  Christian Besler; Thomas F Lüscher; Ulf Landmesser
Journal:  EMBO Mol Med       Date:  2012-03-16       Impact factor: 12.137

9.  Genetics of Dyslipidemia.

Authors:  Diego García-Giustiniani; Ricardo Stein
Journal:  Arq Bras Cardiol       Date:  2016-05       Impact factor: 2.000

Review 10.  High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis.

Authors:  Alice Ossoli; Chiara Pavanello; Laura Calabresi
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.